Article
Viral infection triggers rapid differentiation of human blood monocytes into dendritic cells.
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Blood (impact factor:
9.9).
02/2012;
119(13):3128-31.
DOI:10.1182/blood-2011-09-379479
pp.3128-31
Source: PubMed
- Citations (1)
-
Cited In (0)
-
Article: The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement.
[show abstract] [hide abstract]
ABSTRACT: A novel dendritic cell (DC)-restricted molecule, Clec9A, was identified by gene expression profiling of mouse DC subtypes. Based on sequence similarity, a human ortholog was identified. Clec9A encodes a type II membrane protein with a single extracellular C-type lectin domain. Both the mouse Clec9A and human CLEC9A were cloned and expressed, and monoclonal antibodies (mAbs) against each were generated. Surface staining revealed that Clec9A was selective for mouse DCs and was restricted to the CD8(+) conventional DC and plasmacytoid DC subtypes. A subset of human blood DCs also expressed CLEC9A. A single injection of mice with a mAb against Clec9A, which targets antigens (Ags) to the DCs, produced a striking enhancement of antibody responses in the absence of added adjuvants or danger signals, even in mice lacking Toll-like receptor signaling pathways. Such targeting also enhanced CD4 and CD8 T-cell responses. Thus, Clec9A serves as a new marker to distinguish subtypes of both mouse and human DCs. Furthermore, targeting Ags to DCs with antibodies to Clec9A is a promising strategy to enhance the efficiency of vaccines, even in the absence of adjuvants.Blood 08/2008; 112(8):3264-73. · 9.90 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
activate innate
activate T cells
antiviral immunity
blood mononuclear cells
cell division
dendritic cells
differentiate
hijack host cell biosynthetic capacity
human blood mononuclear cells
infectious virus
likely purpose
lytic viruses
monocytes
peripheral blood mononuclear cells
predominant cell type
vesicular stomatitis virus
viral infection
viral protein synthesis
viral proteins
viruses ex vivo